Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tadokoro

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Ryoikibetsu Shokogun Shirizu|December 16, 1998
[Chronic myelomonocytic leukemia]S Furusawa, J Tadokoro
International Journal of Hematology|May 25, 2001
Low frequency of BCL10 gene mutations in B-cell non-Hodgkin's lymphomaJ Tadokoro, Y Nakamura, S Furusawa, et al.
[Kango Kyoiku] Japanese Journal of Nurses' Education|August 1, 1970
[Concept of nursing among female high school students]M Itakura, F Kitamura, J Tadokoro, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 10, 2001
[Primary renal non-Hodgkin's lymphoma presenting as immune thrombocytopenia]J Tadokoro, H Gunji, T Handa, et al.
Radioisotopes|February 1, 1980
[A comparative study between pancreas scintigraphy and endoscopic retrograde pancreatic parenchymography (author's transl)]R Onishi, S Yoshimoto, J Tadokoro, et al.
Leukemia|November 24, 2006
Chronic idiopathic myelofibrosis expressing a novel type of TEL-PDGFRB chimaera responded to imatinib mesylate therapyK Tokita, K Maki, J Tadokoro, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2000
[CD19-positive acute myeloblastic leukemia developed 12 years after the onset of hypereosinophilic syndrome]T Handa, K Yamamoto, J Tadokoro, et al.
Radioisotopes|August 1, 1979
[A comparative study, by objective quantization using microdensitometry, between cardiac pool images obtained using red blood cells labeled in vivo with 99mTc and using 99mTc-human serum albumin (author's transl)]M Matsuo, T Uehara, S Yoshimoto, et al.
International Journal of Hematology|June 10, 2000
Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformationK Saito, Y Nakamura, M Aoyagi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Ryoikibetsu Shokogun Shirizu|December 16, 1998
[Chronic myelomonocytic leukemia]S Furusawa, J Tadokoro
International Journal of Hematology|May 25, 2001
Low frequency of BCL10 gene mutations in B-cell non-Hodgkin's lymphomaJ Tadokoro, Y Nakamura, S Furusawa, et al.
[Kango Kyoiku] Japanese Journal of Nurses' Education|August 1, 1970
[Concept of nursing among female high school students]M Itakura, F Kitamura, J Tadokoro, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 10, 2001
[Primary renal non-Hodgkin's lymphoma presenting as immune thrombocytopenia]J Tadokoro, H Gunji, T Handa, et al.
Radioisotopes|February 1, 1980
[A comparative study between pancreas scintigraphy and endoscopic retrograde pancreatic parenchymography (author's transl)]R Onishi, S Yoshimoto, J Tadokoro, et al.
Leukemia|November 24, 2006
Chronic idiopathic myelofibrosis expressing a novel type of TEL-PDGFRB chimaera responded to imatinib mesylate therapyK Tokita, K Maki, J Tadokoro, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2000
[CD19-positive acute myeloblastic leukemia developed 12 years after the onset of hypereosinophilic syndrome]T Handa, K Yamamoto, J Tadokoro, et al.
Radioisotopes|August 1, 1979
[A comparative study, by objective quantization using microdensitometry, between cardiac pool images obtained using red blood cells labeled in vivo with 99mTc and using 99mTc-human serum albumin (author's transl)]M Matsuo, T Uehara, S Yoshimoto, et al.
International Journal of Hematology|June 10, 2000
Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformationK Saito, Y Nakamura, M Aoyagi, et al.
Pageof 1